Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.311
Abstract: 311Background: Stereotactic ablative radiotherapy (SAbR) is a promising treatment option for selected oligometastatic renal cell carcinoma (RCC) patients that can provide longitudinal disease contr... read more here.
Keywords: stereotactic ablative; radiation sabr; ablative radiation; phase trial ... See more keywords